M
Maryse Guay
Researcher at Université de Sherbrooke
Publications - 57
Citations - 2421
Maryse Guay is an academic researcher from Université de Sherbrooke. The author has contributed to research in topics: Vaccination & Public health. The author has an hindex of 17, co-authored 55 publications receiving 1556 citations.
Papers
More filters
Journal ArticleDOI
Vaccine hesitancy: An overview
TL;DR: This review provides an overview of the phenomenon of vaccine Hesitancy and suggests the possible causes of the apparent increase in vaccine hesitancy in the developed world.
Journal ArticleDOI
“Nature Does Things Well, Why Should We Interfere?” Vaccine Hesitancy Among Mothers
TL;DR: The results show the heterogeneity of factors influencing vaccine decision making and although the majority of vaccine-hesitant mothers finally chose to follow the recommended vaccine schedule for their child, they were still ambivalent and they continued to question their decision.
Journal ArticleDOI
Understanding Vaccine Hesitancy in Canada: Results of a Consultation Study by the Canadian Immunization Research Network.
Eve Dubé,Dominique D. Gagnon,Manale Ouakki,Julie A. Bettinger,Maryse Guay,Scott A. Halperin,Kumanan Wilson,Janice E. Graham,Holly O. Witteman,Shannon E. MacDonald,Shannon E. MacDonald,William E. Fisher,Laurence Monnais,Dat Tran,Arnaud Gagneur,Juliet R. Guichon,Vineet Saini,Vineet Saini,Jane M. Heffernan,Samantha B Meyer,S. Michelle Driedger,Joshua Greenberg,Heather MacDougall +22 more
TL;DR: It is indicated that both vaccine experts and front-line vaccine providers have the perception that vaccine rates have been declining and consider vaccine hesitancy an important issue to address in Canada.
Journal ArticleDOI
The burden of pneumococcal disease in the Canadian population before routine use of the seven-valent pneumococcal conjugate vaccine.
TL;DR: The burden of pneumonia before routine use of the pneumococcal conjugate vaccine was substantial in all age groups of the Canadian population and provides a baseline for further analysis of the direct and indirect impacts of the vaccine.
Journal ArticleDOI
Benefits and costs of immunization of children with pneumococcal conjugate vaccine in Canada.
Philippe De Wals,Geneviève Petit,Lonny J. Erickson,Maryse Guay,Theresa W. S. Tam,Barbara Law,Alicia Framarin +6 more
TL;DR: To estimate cost-effectiveness of routine and catch-up vaccination of Canadian children with seven-valent pneumococcal conjugate vaccine, a simulation model was constructed and vaccine purchase cost is the most important variable in sensitivity analyses.